For decades, scientists have been trying to figure out how to replenish vital insulin-producing beta cells that are missing in type 1 diabetes, which affects an estimated 1.25 million children and adults in the United States. Indeed, major inroads have been made in engineering functional insulin cells in the lab that could be used as cell replacement therapies for treating diabetes. But one of the limitations of these experimental therapies is that, in type 1 diabetes, the body continues to inflict damage on native and transplanted insulin cells. So, some scientists believe a more desirable approach would involve a treatment in which beta cells could be produced in a renewable fashion to counteract their loss in the body.

from Forbes – Tech http://ift.tt/1TAZZQx
via IFTTT